Anti-Inflammatory Lipoxin A4 Is an Endogenous Allosteric Enhancer of CB1 Cannabinoid Receptor

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1202906109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Lipoxin A4 Is an Allosteric Endocannabinoid That Strengthens Anandamide-Induced CB1 Receptor Activation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

The CB1 Cannabinoid Receptor Is Coupled to the Activation of Protein Kinase B/Akt

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2000English

Lipoxin A4 Activates ALX/FPR2 Receptor to Regulate Conjunctival Goblet Cell Secretion

Mucosal Immunology
AllergyImmunology
2016English

High-Resolution Crystal Structure of the Human CB1 Cannabinoid Receptor

2016English

CB1 Cannabinoid Receptor Expression in the Barrel Field Region Is Associated With Mouse Learning

English

A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding

Journal of Neuroscience
Neuroscience
2002English

Μ Opioid and CB1 Cannabinoid Receptor Interactions: Reciprocal Inhibition of Receptor Signaling and Neuritogenesis

British Journal of Pharmacology
Pharmacology
2009English

Development of Indole Sulfonamides as Cannabinoid Receptor Negative Allosteric Modulators

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

P087 the Anti-Inflammatory Cytokine Interleukin 37 Is an Endogenous Inhibitor of Trained Immunity

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy